← Back to CPIX

Cumberland Pharmaceuticals Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 08/05/2026Dec 2025Filed 09/03/2026Sep 2025Filed 09/03/2026Jun 2025Filed 07/08/2026Mar 2025Filed 08/05/2026Dec 2024Filed 09/03/2026Sep 2024Filed 09/03/2026
$8.8$9.1$14$8.3$11$12$10$9.1
−$4.3−$3.3−$1.4−$1.9−$0.7$1.3−$1.9−$1.5
−$0.29−$0.22−$0.09−$0.13−$0.05$0.08−$0.14−$0.11
151515151514

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.